{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:27:34Z","timestamp":1765268854537,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU17CE924986"],"award-info":[{"award-number":["NU17CE924986"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.japh.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T16:43:18Z","timestamp":1659804198000},"page":"204-211.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overcoming challenges in acute care hospitalizations for patients with opioid use disorder"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-8677","authenticated-orcid":false,"given":"Angela","family":"Kerins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-4090","authenticated-orcid":false,"given":"Mim","family":"Ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-6679","authenticated-orcid":false,"given":"John P.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-1159","authenticated-orcid":false,"given":"George","family":"Weyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2022.08.004_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.japh.2022.08.004_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","article-title":"\u201cMaybe if I stop the drugs, then maybe they\u2019d care?\u201d-hospital care experiences of people who use drugs","volume":"16","author":"Chan Carusone","year":"2019","journal-title":"Harm Reduct J"},{"issue":"12","key":"10.1016\/j.japh.2022.08.004_bib5","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"issue":"14","key":"10.1016\/j.japh.2022.08.004_bib6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention stigma toward medications for opioid use disorder: a systematic review","volume":"56","author":"Madden","year":"2021","journal-title":"Subst Use Misuse"},{"issue":"16","key":"10.1016\/j.japh.2022.08.004_bib7","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.japh.2022.08.004_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.japh.2022.08.004_bib9","first-page":"CD002025","article-title":"Buprenorphine for managing opioid withdrawal","volume":"2","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.japh.2022.08.004_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","article-title":"\u201cIt\u2019s been an Experience, a Life Learning Experience\u201d: a qualitative study of hospitalized patients with substance use disorders","volume":"32","author":"Velez","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"doi-asserted-by":"crossref","unstructured":"American Society of Addiction Medicine. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update [published correction appears in J Addict Med. 2020;14(3):267]. J Addict Med. 2020;14(2S suppl 1):1\u201391.","key":"10.1016\/j.japh.2022.08.004_bib11","DOI":"10.1097\/ADM.0000000000000633"},{"issue":"1","key":"10.1016\/j.japh.2022.08.004_bib12","first-page":"50","article-title":"Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis","volume":"6","author":"Walley","year":"2012","journal-title":"J\u00a0Addict Med"},{"issue":"6","key":"10.1016\/j.japh.2022.08.004_bib13","first-page":"421","article-title":"Patients with substance use disorders leaving against medical advice: strategies for improvement","volume":"12","author":"Lail","year":"2018","journal-title":"J\u00a0Addict Med"},{"author":"Bridge","key":"10.1016\/j.japh.2022.08.004_bib14"},{"issue":"2","key":"10.1016\/j.japh.2022.08.004_bib15","first-page":"104","article-title":"Role of the hospital in the 21st century opioid overdose epidemic: the Addiction Medicine Consult Service","volume":"13","author":"Priest","year":"2019","journal-title":"J\u00a0Addict Med"},{"issue":"8","key":"10.1016\/j.japh.2022.08.004_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2022.08.004_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-019-0135-7","article-title":"Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment","volume":"14","author":"McNeely","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"10","key":"10.1016\/j.japh.2022.08.004_bib18","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s11606-021-07362-8","article-title":"Inpatient addiction medicine consultation service impact on post-discharge patient mortality: a propensity-matched analysis","volume":"37","author":"Wilson","year":"2022","journal-title":"J\u00a0Gen Intern Med"},{"doi-asserted-by":"crossref","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016 [published correction appears in MMWR Recomm Rep. 2016;65(11):295]. MMWR Recomm Rep. 2016;65(1):1\u201349.","key":"10.1016\/j.japh.2022.08.004_bib19","DOI":"10.15585\/mmwr.rr6501e1er"},{"key":"10.1016\/j.japh.2022.08.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108265","article-title":"Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids","volume":"216","author":"Winhusen","year":"2020","journal-title":"Drug Alcohol Depend"},{"unstructured":"Tabriz, A. Agile Project Management and its application in Medical Practice. July 27, 2020. Available at:. Agile Project Management and its Application in Medical Practice | DataDrivenInvestor. Accessed August 27, 2002.","key":"10.1016\/j.japh.2022.08.004_bib21"},{"unstructured":"Code of Federal Regulations. Title 42. CFR - Part 8 - Section 8.12 Federal opioid treatment standards. Available at: eCFR :: 42 CFR 8.12 -- Federal opioid treatment standards. Accessed March 29, 2022.","key":"10.1016\/j.japh.2022.08.004_bib22"},{"unstructured":"Code of Federal Regulations. Title 21. CFR \u2013 Part 21 \u2013 Section 1306.07 --Administering or dispensing of narcotic drugs. Available at: eCFR :: 21 CFR 1306.07 -- Administering or dispensing of narcotic drugs. Accessed March 29,\u00a02022.","key":"10.1016\/j.japh.2022.08.004_bib23"},{"issue":"4","key":"10.1016\/j.japh.2022.08.004_bib24","first-page":"e265","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2022","journal-title":"J\u00a0Addict Med"},{"issue":"12","key":"10.1016\/j.japh.2022.08.004_bib25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1360-0443.2009.02724.x","article-title":"Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose","volume":"104","author":"Kerr","year":"2009","journal-title":"Addiction"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122002746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122002746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:30Z","timestamp":1761544350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122002746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1544319122002746"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.08.004","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming challenges in acute care hospitalizations for patients with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}